Lenvatinib

Common brands: Lenvima, Keytruda, Afinitor Disperz, Afinitor, Katerzia

Top reporter: Eisai Inc.

Kinase Inhibitor [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]mTOR Inhibitor Immunosuppressant [EPC]Dihydropyridine Calcium Channel Blocker [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
31,670
Total Reports
20,924
Serious Reports
4,321
Death Reports
30
Reported Reactions
Death Report Ratio: High (13.64%)

Patient Demographics

Male
14,926
Female
15,292

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Lenvatinib.

# Reaction Reports % of Total
1 DIARRHOEA 4,005
9.0%
2 HYPERTENSION 3,571
8.0%
3 FATIGUE 3,214
7.2%
4 DECREASED APPETITE 3,051
6.9%
5 NAUSEA 2,401
5.4%
6 MALIGNANT NEOPLASM PROGRESSION 2,305
5.2%
7 BLOOD PRESSURE INCREASED 2,071
4.7%
8 VOMITING 1,935
4.4%
9 ASTHENIA 1,571
3.5%
10 DEHYDRATION 1,485
3.3%
11 WEIGHT DECREASED 1,403
3.2%
12 MALAISE 1,286
2.9%
13 PYREXIA 1,225
2.8%
14 HEADACHE 1,154
2.6%
15 HYPOTHYROIDISM 1,052
2.4%
16 PROTEINURIA 1,014
2.3%
17 DEATH 981
2.2%
18 RASH 970
2.2%
19 STOMATITIS 956
2.2%
20 PLATELET COUNT DECREASED 954
2.1%
21 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 942
2.1%
22 CONSTIPATION 867
2.0%
23 DYSPHONIA 860
1.9%
24 ARTHRALGIA 853
1.9%
25 ABDOMINAL PAIN 843
1.9%
26 DYSPNOEA 821
1.8%
27 PAIN 728
1.6%
28 PNEUMONIA 673
1.5%
29 INTERSTITIAL LUNG DISEASE 651
1.5%
30 DIZZINESS 610
1.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.